Back
In COVID-19 disease, the kidneys are commonly affected; we can see abnormal dipstick or acute kidney injury (AKI), the latter of which is associated with mortality in children and adults. NGAL and Cystatin C are biomarkers that increase after kidney injury. Recognition of AKI is sometimes late; identification would help to improve the outcomes. There are few studies evaluating kidney function in children and adults. This work aims to describe the kidney function with creatinine and urinary levels of NGAL and cystatin C, hematuria, and/or proteinuria in patients hospitalized with COVID-19.
Prospective cohort study (July-September 2020), patients of any age hospitalized for COVID-19 were screened, including only confirmed cases and exclusion: Chronic Kidney Disease (CKD) stage 2 or more. Upon hospital admission and discharge, blood chemistry general, urinalysis, NGAL, and Cystatin C urinary were evaluated; genetic variants of the APOL1 gene were measured. Those patients identified with hematuria and/or proteinuria or acute kidney injury were analyzed.
525 patients were screened, 378 children (40 included) and 162 adults (119 included). General characteristics, we found 42% of Children with COVID-19 had illness genetic y/o malformations and 49.4% of adults with obesity. The predominant symptom in children was fever (60%) vs. dyspnea in adults (73%). Adults had higher mortality, 31.1% vs 2.5% in children. Kidney function was evaluated by GFR and urinalysis, acute kidney injury and/or hematuria-proteinuria was identified (Table 1)
Table 1. Kidney function by eGFR and urinalysis of children and adults at the time of COVID-19 diagnosis and follow-up
Children
n=40
Adults
n=119
p<0.05*
eGFR
Initial (median, min-max)
Follow-up (median, min-max)
91.71 (17-189) IQR 34
145.73 (41.3-225.27) IQR 26.25†
97 (11-145) IQR 35
106 (13-140) IQR 22†
0.588
0.008ₑ*
Hematuria
Initial n(%)
Follow-up n(%)
11 (27.5)
7 (17.5)*
55 (46.2)
11 (9.3) *
0.076
0.263
Proteinuria
Initial n (%)
Follow-up n (%)
22 (55)
13 (32.5) *
85 (71.4)
9 (6.7) *
Children with COVID-19 had lower AKI than adults (22.5 vs. 45.4), as well as lower mortality.
Urinary cystatin C was higher at the admission visit than at subsequent visits in both children and adults, but the change was significant only in adults.
We found no relationship between APOL1 genetic variants and the severity of kidney damage.